Targeted proteomics signature identifies corticosteroid binding globulin peptides as highly predictive of treatment response in IL28B unfavorable genotype patients
Publication
, Conference
Naggie, S; Osinusi, A; Himmel, T; Lucas, J; Thompson, JW; Dubois, LG; Moseley, MA; Clark, PJ; Kottilil, S; Patel, K
Published in: HEPATOLOGY
October 1, 2012
Duke Scholars
Published In
HEPATOLOGY
ISSN
0270-9139
Publication Date
October 1, 2012
Volume
56
Start / End Page
999A / 1000A
Location
Boston, MA
Publisher
WILEY-BLACKWELL
Conference Name
63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Naggie, S., Osinusi, A., Himmel, T., Lucas, J., Thompson, J. W., Dubois, L. G., … Patel, K. (2012). Targeted proteomics signature identifies corticosteroid binding globulin peptides as highly predictive of treatment response in IL28B unfavorable genotype patients. In HEPATOLOGY (Vol. 56, pp. 999A-1000A). Boston, MA: WILEY-BLACKWELL.
Naggie, Susanna, Anu Osinusi, Tiffany Himmel, Joseph Lucas, J. W. Thompson, Laura G. Dubois, Martin A. Moseley, Paul J. Clark, Shyam Kottilil, and Keyur Patel. “Targeted proteomics signature identifies corticosteroid binding globulin peptides as highly predictive of treatment response in IL28B unfavorable genotype patients.” In HEPATOLOGY, 56:999A-1000A. WILEY-BLACKWELL, 2012.
Naggie S, Osinusi A, Himmel T, Lucas J, Thompson JW, Dubois LG, et al. Targeted proteomics signature identifies corticosteroid binding globulin peptides as highly predictive of treatment response in IL28B unfavorable genotype patients. In: HEPATOLOGY. WILEY-BLACKWELL; 2012. p. 999A-1000A.
Naggie, Susanna, et al. “Targeted proteomics signature identifies corticosteroid binding globulin peptides as highly predictive of treatment response in IL28B unfavorable genotype patients.” HEPATOLOGY, vol. 56, WILEY-BLACKWELL, 2012, pp. 999A-1000A.
Naggie S, Osinusi A, Himmel T, Lucas J, Thompson JW, Dubois LG, Moseley MA, Clark PJ, Kottilil S, Patel K. Targeted proteomics signature identifies corticosteroid binding globulin peptides as highly predictive of treatment response in IL28B unfavorable genotype patients. HEPATOLOGY. WILEY-BLACKWELL; 2012. p. 999A-1000A.
Published In
HEPATOLOGY
ISSN
0270-9139
Publication Date
October 1, 2012
Volume
56
Start / End Page
999A / 1000A
Location
Boston, MA
Publisher
WILEY-BLACKWELL
Conference Name
63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics